Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 400
- Avg volume
- —
- Day's range
- $2.43 – $2.43
- Shares out
- —
- Stochastic %K
- 10%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields; and surfactant-like peptide, as well as High Concentration PuraMatrix, a high concentration hydrogel; and GMP Grade PuraMatrix. The c...
Show more
3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields; and surfactant-like peptide, as well as High Concentration PuraMatrix, a high concentration hydrogel; and GMP Grade PuraMatrix. The company was incorporated in 2004 and is based in Tokyo, Japan.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 81 3 3511 3440
- Website
- https://www.3d-matrix.co.jp
- Address
- Kojimachi HF Building, 7th Floor 3-2-4 Kojimachi Chiyoda-ku, Tokyo, Japan
Latest news
No headlines yet.
